CMS NCD 32 Updated: What Billing Teams Need to Know About Impotence Diagnosis and Treatment Coverage

CMS has modified National Coverage Determination (NCD) 32, which governs Medicare coverage for the diagnosis and treatment of impotence. This policy update—effective March 12, 2026—touches two Medicare benefit categories: Diagnostic Tests (other) and Physicians' Services. Urology, urogynecology, psychiatry, and general surgery practices billing Medicare for these services need to review their documentation workflows now.

What CMS NCD 32 Covers: Medicare Impotence Policy Explained

The Centers for Medicare & Medicaid Services recognizes impotence as a medically significant condition requiring professional diagnosis and, in many cases, specialized treatment. NCD 32 explicitly acknowledges that causes of impotence vary substantially from patient to patient—which is exactly why documentation of medical necessity carries so much weight on these claims.

Under this policy, Medicare program payment may be made for both the diagnosis and treatment of sexual impotence. The policy covers a range of treatment modalities, reflecting the fact that the appropriate intervention depends on the underlying etiology. Surgical options—such as implantation of a penile prosthesis—are addressed alongside nonsurgical approaches, including medical management and psychotherapeutic treatment.

This is not a blanket coverage policy with no conditions. CMS is explicit that if abuse is suspected, contractors may request documentation of appropriateness on a case-by-case basis. Billing teams should treat that clause as a standing audit risk: any claim that looks unusual in frequency, pattern, or cost is a candidate for documentation requests.

Surgical vs. Nonsurgical Treatment: How Coverage Applies Under NCD 32

One of the most practically important aspects of NCD 32 is its recognition that impotence treatment is not one-size-fits-all. CMS separates treatment pathways into two broad categories:

Surgical treatment — The policy cites penile prosthesis implantation as the primary surgical example. These claims typically carry higher reimbursement and, accordingly, higher scrutiny. Strong operative notes, pre-operative diagnostic workups, and documented failure of nonsurgical alternatives will be essential if you're billing prosthesis-related services.

Nonsurgical treatment — This includes both pharmacological management and psychotherapeutic approaches. Medical management is increasingly common and, depending on the drugs prescribed and the setting, may cross into Part D territory rather than Part B. Psychotherapeutic treatment, however, triggers a specific limitation that your billing team must understand.

The Psychiatric Service Limitation: A Critical Billing Boundary

This is the section of NCD 32 that billing managers most commonly miss, and it's where claims are most vulnerable to denial.

When impotence treatment is furnished to patients who are not hospital inpatients and the treatment is connected to a mental health condition, CMS directs contractors to apply the psychiatric service limitation. That limitation is detailed in Chapter 3 of the Medicare General Information, Eligibility, and Entitlement Manual.

In practical terms, this means: if a patient's impotence has a psychogenic etiology and they're receiving outpatient psychotherapy or psychiatric care, the psychiatric outpatient benefit cap applies. Medicare historically limited outpatient mental health benefits at a different coinsurance rate than other Part B services—though parity rules have shifted this over time, the procedural and documentation requirements remain distinct.

Your psychiatry and behavioral health billers need to be coordinating with urology on any shared patient cases. A claim that falls under this limitation, billed without the appropriate mental health coding and documentation framework, is at real risk of denial or post-payment audit recovery.

Abuse Screening and Documentation Requirements Under CMS NCD 32

CMS includes language in this policy that should prompt a documentation protocol review at any practice billing these services regularly. The policy states: if abuse is suspected, it may be necessary to request documentation of appropriateness in individual cases.

"Abuse" in this context refers to billing abuse—patterns of billing that deviate from sound fiscal, business, or medical practices. This is distinct from fraud, but it can trigger the same prepayment or post-payment review processes.

The practical implication is that your claims should proactively support medical necessity even before a documentation request arrives. That means:

• Diagnostic workup notes supporting the impotence diagnosis
• Documentation of the treatment decision rationale (why surgical vs. nonsurgical)
• Evidence of shared decision-making with the patient where applicable
• Clear linkage between the diagnosis and the specific treatment billed

Affected Codes

The current version of NCD 32 does not list specific CPT, HCPCS, or ICD-10 codes within the policy document. CMS directs billing questions to its Claims Processing Instructions for code-level guidance.

Given this, your billing team should cross-reference the following resources to identify the appropriate codes for impotence-related services billed under this NCD:

• CMS Claims Processing Manual for applicable HCPCS and CPT guidance
• Your MAC's (Medicare Administrative Contractor's) Local Coverage Determinations (LCDs) — many MACs have issued complementary LCDs that specify covered CPT codes for penile prosthesis implantation and impotence diagnostics in your jurisdiction
• ICD-10-CM codes in the N52.x range (Male erectile dysfunction) are the most directly relevant diagnosis codes, but confirm against your MAC's LCD before billing

Because no codes are enumerated in NCD 32 itself, do not assume national uniformity. Check your MAC's current LCD and billing articles before submitting claims.

What Your Billing Team Should Do